Emerging Trends in Consumer Protection: A Conversation With NAAG’s Kate Donoven - Regulatory Oversight Podcast
A Look Ahead to the 2024 State AG Elections From DAGA President Sean Rankin — Regulatory Oversight Podcast
The Executive Appointment Process
Podcast - What’s Next After Gov. Gavin Newsom’s Veto in California?
Podcast - Ruling: Las mujeres toman cerveza a los 18 años
Recent Developments in Florida Energy and Environmental Legislation
Mitigating and Addressing Litigation Risks for Cannabis Businesses
Florida’s Equine Landscape
Cannabis M&A: Pain Points and Opportunities
Haight Partner Greg Rolen Testifies About SB 907 Before the California State Assembly
Intellectual property considerations for launching new cannabis products
Unpacking the current cannabis regulatory landscape and how it impacts your business
In That Case: Alexander v. South Carolina State Conference of the NAACP
Mitigating Political-Law Risk
The Presumption of Innocence Podcast: Episode 40 - Debunking Courtroom Pseudoscience: A Conversation With the Innocence Project's Chris Fabricant
State AG Pulse | The State AG: Both Advocate & Influencer
Work This Way: A Labor & Employment Law Podcast - Episode 21: Economic, Industry, and Workforce Development in the City of Greenville with Mayor Knox White
State AG Pulse | Changing of the Guard in the PNW
PODCAST: Williams Mullen's Gavels & Gowns - What’s Next in VA K-12 Education? An Interview with Scott Brabrand, Executive Director of VASS
Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake – Diagnosing Health Care
State Attorneys General play a significant role in shaping health care policy across the country. While the national debates over health care policy in Congress and the federal government receive significant media attention,...more
The US Supreme Court heard oral arguments on Wednesday in the consolidated cases of Moyle v. United States, Case No. 23-726 and Idaho v. United States, Case No. 23-727. These cases asked the justices to consider whether the...more
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
The U.S. Food and Drug Administration’s (“FDA”) approval of the commonly-used abortion medication, Mifepristone, has been curtailed following dueling federal court decisions in Texas and Washington. Just days after a Texas...more